Teachers Retirement System Of The State Of Kentucky Bei Gene, Ltd. Transaction History

Teachers Retirement System Of The State Of Kentucky

$11.1 Billion
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$107.01 - $175.15 $1.44 Million - $2.35 Million	-13,439 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$152.5 - $216.77 $447,282 - $635,786	-2,933 Reduced 17.91%	13,439 $2.07 Million
Q1 2018 May 11, 2018	BUY	$97.41 - $177.22 $249,077 - $453,151	2,557 Added 18.51%	16,372 $2.75 Million
Q4 2017 Feb 14, 2018	BUY	$79.6 - $114.73 $1.1 Million - $1.58 Million	13,815	13,815 $1.35 Million

Others Institutions Holding BGNE

# of Institutions

244

Shares Held

45.3M

Call Options Held

258K

Put Options Held

52.2K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.22 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$980 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$941 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$701 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.

Account